See more : Centaurus Metals Limited (CTM.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Beijing Chunlizhengda Medical Instruments Co., Ltd. (1858.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Beijing Chunlizhengda Medical Instruments Co., Ltd., a leading company in the Medical – Devices industry within the Healthcare sector.
- PayChest, Inc. (PYCT) Income Statement Analysis – Financial Results
- National Silicon Industry Group Co., Ltd. (688126.SS) Income Statement Analysis – Financial Results
- Peninsula Group Ltd (PEN.TA) Income Statement Analysis – Financial Results
- Q Technology Group Limited (QTG.AX) Income Statement Analysis – Financial Results
- Aldrees Petroleum and Transport Services Company (4200.SR) Income Statement Analysis – Financial Results
Beijing Chunlizhengda Medical Instruments Co., Ltd. (1858.HK)
About Beijing Chunlizhengda Medical Instruments Co., Ltd.
Beijing Chunlizhengda Medical Instruments Co., Ltd., an orthopedic medical device company, engages in the research and development, production, and sale of surgical implants, instruments, and related products in the People's Republic of China. It offers implantable orthopedic medical devices, which consist of joint prosthesis products and spinal products. The company primarily sells its products through distributors, or on ODM and OEM bases under the Chunli brand, as well as to hospitals directly. It also exports its products to various countries. The company was incorporated in 1998 and is headquartered in Beijing, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.21B | 1.20B | 1.11B | 937.69M | 855.33M | 497.93M | 300.32M | 207.93M | 177.37M | 134.53M | 110.55M | 98.09M |
| Cost of Revenue | 332.64M | 288.08M | 253.60M | 256.93M | 261.87M | 180.00M | 84.06M | 48.26M | 55.28M | 34.96M | 30.47M | 27.54M |
| Gross Profit | 875.89M | 913.53M | 854.54M | 680.76M | 593.46M | 317.92M | 216.25M | 159.66M | 122.09M | 99.58M | 80.07M | 70.56M |
| Gross Profit Ratio | 72.48% | 76.03% | 77.11% | 72.60% | 69.38% | 63.85% | 72.01% | 76.79% | 68.83% | 74.02% | 72.44% | 71.93% |
| Research & Development | 157.45M | 162.34M | 104.84M | 72.60M | 57.75M | 35.45M | 21.22M | 14.28M | 13.32M | 8.00M | 4.81M | 4.87M |
| General & Administrative | 9.70M | 10.95M | 10.68M | 14.20M | 7.38M | 6.21M | 6.89M | 6.09M | 24.34M | 18.55M | 13.58M | 14.86M |
| Selling & Marketing | 269.47M | 288.89M | 342.05M | 241.01M | 225.79M | 143.91M | 88.95M | 52.23M | 23.62M | 12.93M | 8.32M | 16.14M |
| SG&A | 279.17M | 299.84M | 352.74M | 255.21M | 233.17M | 150.12M | 95.84M | 58.32M | 47.96M | 31.49M | 21.91M | 33.20M |
| Other Expenses | 133.30M | 119.01M | 11.73M | 18.10M | 18.76M | -150.40K | -185.57K | -587.41K | 22.12M | 664.44K | 586.44K | 0.00 |
| Operating Expenses | 569.91M | 581.19M | 469.31M | 345.92M | 309.68M | 201.14M | 135.24M | 86.37M | 83.40M | 56.31M | 41.90M | 33.52M |
| Cost & Expenses | 902.55M | 869.27M | 722.90M | 602.85M | 571.54M | 381.15M | 219.31M | 134.63M | 138.68M | 91.26M | 72.37M | 61.06M |
| Interest Income | 14.46M | 16.86M | 10.76M | 6.27M | 6.21M | 5.40M | 5.50M | 4.53M | 3.36M | 172.56K | 200.96K | 165.24K |
| Interest Expense | 364.86K | 16.21M | 256.55K | 141.60K | 4.89M | 1.73M | 8.39M | 4.35M | 95.22K | 67.73K | 46.18K | 0.00 |
| Depreciation & Amortization | 34.66M | 30.03M | 18.31M | 14.95M | 11.80M | 7.42M | 6.51M | 6.00M | 4.86M | 4.06M | 3.95M | 3.08M |
| EBITDA | 340.65M | 366.96M | 360.99M | 349.78M | 295.58M | 124.20M | 87.52M | 79.30M | 44.39M | 48.02M | 42.07M | 39.23M |
| EBITDA Ratio | 28.19% | 31.88% | 38.87% | 37.90% | 36.29% | 25.83% | 31.20% | 40.44% | 24.74% | 35.88% | 38.88% | 39.99% |
| Operating Income | 305.98M | 328.91M | 367.59M | 330.10M | 298.58M | 121.18M | 87.19M | 78.09M | 39.03M | 44.21M | 39.03M | 36.15M |
| Operating Income Ratio | 25.32% | 27.37% | 33.17% | 35.20% | 34.91% | 24.34% | 29.03% | 37.56% | 22.00% | 32.86% | 35.31% | 36.85% |
| Total Other Income/Expenses | -69.60K | 7.97M | -212.93K | -248.95K | -25.58M | 2.67M | -185.57K | 449.99K | 4.47M | 664.45K | -912.52K | 1.05M |
| Income Before Tax | 305.91M | 336.88M | 367.38M | 329.85M | 273.00M | 119.45M | 78.80M | 73.74M | 43.49M | 42.91M | 38.12M | 37.20M |
| Income Before Tax Ratio | 25.31% | 28.04% | 33.15% | 35.18% | 31.92% | 23.99% | 26.24% | 35.47% | 24.52% | 31.90% | 34.48% | 37.93% |
| Income Tax Expense | 28.09M | 29.16M | 45.02M | 46.47M | 36.24M | 13.80M | 10.51M | 10.30M | 5.63M | 5.88M | 5.45M | 5.26M |
| Net Income | 277.82M | 307.72M | 322.36M | 283.37M | 236.76M | 105.65M | 68.28M | 63.44M | 37.87M | 37.03M | 32.67M | 31.94M |
| Net Income Ratio | 22.99% | 25.61% | 29.09% | 30.22% | 27.68% | 21.22% | 22.74% | 30.51% | 21.35% | 27.53% | 29.55% | 32.56% |
| EPS | 0.72 | 0.80 | 0.93 | 0.82 | 0.68 | 0.31 | 0.20 | 0.18 | 0.12 | 0.15 | 0.13 | 0.13 |
| EPS Diluted | 0.72 | 0.80 | 0.93 | 0.82 | 0.68 | 0.31 | 0.20 | 0.18 | 0.12 | 0.15 | 0.13 | 0.13 |
| Weighted Avg Shares Out | 385.87M | 383.57M | 346.62M | 345.58M | 345.85M | 345.85M | 344.87M | 344.79M | 345.85M | 250.00M | 250.00M | 250.00M |
| Weighted Avg Shares Out (Dil) | 385.87M | 384.65M | 346.62M | 345.58M | 348.18M | 345.85M | 345.85M | 345.85M | 345.85M | 250.00M | 250.00M | 250.00M |
Source: https://incomestatements.info
Category: Stock Reports